Healthpeak Properties (NYSE:DOC) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen cut shares of Healthpeak Properties (NYSE:DOC - Free Report) from a hold rating to a sell rating in a report published on Saturday morning.

Several other research analysts also recently commented on DOC. Wedbush decreased their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Evercore ISI cut their price objective on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Scotiabank decreased their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a report on Monday, May 12th. Robert W. Baird dropped their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Finally, Argus reiterated a "buy" rating and set a $25.00 price target on shares of Healthpeak Properties in a research report on Tuesday, April 29th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $23.27.

Healthpeak Properties Price Performance

DOC traded down $0.01 on Friday, reaching $17.48. The company had a trading volume of 7,298,786 shares, compared to its average volume of 5,215,662. The business has a 50 day simple moving average of $17.58 and a 200 day simple moving average of $19.21. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.35 and a current ratio of 1.35. The company has a market cap of $12.15 billion, a price-to-earnings ratio of 43.71, a P/E/G ratio of 1.95 and a beta of 1.05. Healthpeak Properties has a 52-week low of $16.64 and a 52-week high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. The company had revenue of $702.89 million for the quarter, compared to analysts' expectations of $690.76 million. During the same period last year, the firm posted $0.45 EPS. Healthpeak Properties's revenue for the quarter was up 15.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that Healthpeak Properties will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a dividend, which was paid on Friday, May 30th. Investors of record on Tuesday, May 20th were given a dividend of $0.1017 per share. This represents a yield of 7.05%. The ex-dividend date of this dividend was Monday, May 19th. Healthpeak Properties's dividend payout ratio (DPR) is presently 305.00%.

Insider Buying and Selling at Healthpeak Properties

In other news, CEO Scott M. Brinker bought 11,337 shares of the firm's stock in a transaction on Monday, April 28th. The stock was acquired at an average cost of $17.68 per share, with a total value of $200,438.16. Following the completion of the acquisition, the chief executive officer now owns 201,863 shares of the company's stock, valued at approximately $3,568,937.84. This represents a 5.95% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Tommy G. Thompson purchased 5,777 shares of the business's stock in a transaction dated Wednesday, May 28th. The shares were purchased at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the acquisition, the director now owns 144,290 shares of the company's stock, valued at approximately $2,491,888.30. The trade was a 4.17% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 29,764 shares of company stock worth $521,909. 0.23% of the stock is owned by insiders.

Institutional Trading of Healthpeak Properties

A number of institutional investors and hedge funds have recently modified their holdings of the business. Principal Securities Inc. lifted its stake in Healthpeak Properties by 49.5% during the 4th quarter. Principal Securities Inc. now owns 3,592 shares of the real estate investment trust's stock valued at $73,000 after acquiring an additional 1,189 shares during the period. Allworth Financial LP raised its holdings in shares of Healthpeak Properties by 40.8% during the fourth quarter. Allworth Financial LP now owns 4,603 shares of the real estate investment trust's stock valued at $95,000 after purchasing an additional 1,333 shares during the last quarter. CIBC Asset Management Inc lifted its position in Healthpeak Properties by 4.1% during the fourth quarter. CIBC Asset Management Inc now owns 102,460 shares of the real estate investment trust's stock valued at $2,077,000 after purchasing an additional 4,030 shares during the period. Atria Wealth Solutions Inc. boosted its holdings in Healthpeak Properties by 6.6% in the fourth quarter. Atria Wealth Solutions Inc. now owns 67,289 shares of the real estate investment trust's stock worth $1,364,000 after purchasing an additional 4,162 shares during the last quarter. Finally, Kestra Investment Management LLC purchased a new stake in Healthpeak Properties in the fourth quarter worth approximately $45,000. Institutional investors own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.